Unlock the Potential of Fluorinated Organic Intermediates: A Deep Dive into PARP Inhibitor Synthesis
Discover the critical role of 2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile in advancing cancer therapies.
Get a Quote & SampleProduct Core Value
![2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile](https://www.nbinno.com/2025/webimg/gemini_688ac60633ee3_1753925126.png)
2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile
This advanced organic intermediate is pivotal in the synthesis of Poly (ADP-ribose) polymerase (PARP) inhibitors, a vital class of drugs revolutionizing cancer treatment. Its precise chemical structure and high purity make it an indispensable component for pharmaceutical developers seeking to create targeted therapies.
- A crucial component for PARP inhibitor synthesis, enabling the development of novel cancer treatments.
- An essential intermediate in Olaparib production, a well-known PARP inhibitor used in targeted cancer therapy.
- Characterized by its high purity (assay u2265 99.0%), ensuring reliable and consistent results in complex synthesis pathways.
- Exhibits good solubility in common organic solvents like dichloromethane and tetrahydrofuran, facilitating ease of use in various reaction conditions.
Key Advantages
Facilitates Targeted Cancer Therapies
Leveraging this chemical intermediate aids in the creation of targeted cancer treatments, focusing on DNA repair mechanisms within cancer cells.
High Purity for Reliable Synthesis
Ensuring consistent outcomes in pharmaceutical manufacturing is paramount; its high purity guarantees reliable synthesis of complex molecules, vital for pharmaceutical intermediate manufacturing.
Enabling Advanced Drug Discovery
As a key building block for advanced drug discovery, it supports the development of next-generation pharmaceuticals, particularly in the field of oncology, making it a valuable asset for fluorinated organic intermediate synthesis.
Key Applications
PARP Inhibitor Development
This compound serves as a critical intermediate in the synthesis of Poly (ADP-ribose) polymerase (PARP) inhibitors, which are integral to modern oncology research.
Olaparib Synthesis
It is specifically employed as an intermediate in the production of Olaparib, a widely recognized PARP inhibitor used in cancer treatment regimens.
Pharmaceutical Intermediate Manufacturing
The compound is a key component in the broader landscape of pharmaceutical intermediate manufacturing, supporting the creation of various active pharmaceutical ingredients (APIs).
Organic Fluorine Chemistry
Its structure makes it a valuable compound in organic fluorine chemistry, contributing to the development of novel fluorinated compounds for diverse applications.